The cultural diffusion of hockey in Montreal, 1890-1910.

Paper copy at Leddy Library: Theses & Major Papers - Basement, West Bldg. / Call Number: Thesis1986 .V545. Source: Masters Abstracts International, Volume: 40-07, page: . Thesis (M.H.K.)--University of Windsor (Canada), 1986

La naissance d'un sport organisé au Canada : le hockey à Montréal, 1875-1917

Québec Université Laval, Bibliothèque 201

Évaluation des risques que comporte l’exposition aux gras trans au Canada

Trans fats are undesirable because they raise LDL-cholesterol and lower HDL-cholesterol levels in the blood, which can lead to an increased risk of coronary heart disease. In the mid-1990\u27s, researchers estimated that Canadians had one of the highest average trans fat intakes in the world, estimated to be approximately 3.7% of energy. The World Health Organization recommends that average intakes of trans fats should be less than 1% of total energy. As such Canada has pursued a multi-faceted approach to decrease trans fat levels in Canadian foods. Initiatives undertaken include: mandatory nutrition labelling, the establishment of a multi-stakeholder Trans Fat Task Force to develop recommendations and strategies to eliminate trans fat in Canadian foods, and most recently the monitoring of industry\u27s efforts in reducing trans fats from their food products. Collectively, these initiatives have proven successful as average trans fat intakes have been reduced to 1.42% of overall energy. Further reductions in trans fat levels in the Canadian food supply are needed to meet the target of 1% of energy, the associated public health objectives, and the protection of vulnerable populations.Les gras trans sont indésirables, car ils augmentent la concentration sanguine en cholestérol à lipoprotéines de faible densité et abaissent celle en cholestérol à lipoprotéines de haute densité, ce qui peut mener à un risque accru de coronaropathie. Au milieu des années 1990, les chercheurs ont estimé quʹau sein de la population canadienne les apports en gras trans comptaient au nombre des plus élevés au monde en atteignant environ 3,7% de l’apport énergétique. Selon la recommandation de l’Organisation mondiale de la santé, l’apport moyen en gras trans devrait être inférieur à 1% de l’apport énergétique total. Par conséquent, le Canada a adopté une démarche à volets multiples visant à diminuer la teneur en gras trans des aliments canadiens. Les initiatives entreprises sont les suivantes: l’étiquetage nutritionnel obligatoire, l’établissement dʹun groupe de travail multilatéral, soit le Groupe d’étude surles graisses trans, dans le but d’élaborer des recommandations et des stratégies ciblant l’élimination des gras trans dans l’approvisionnement alimentaire canadien et, plus récemment, la surveillance des efforts investis par l’industrie dans la diminution des gras trans contenus dans ses produits. De concert, ces initiatives ont été couronnées de succès alors que l’apport moyen en gras trans a atteint 1,42% de l’apport énergétique total. D’autres réductions de la teneur en gras trans de l’approvisionnement alimentaire au Canada sont essentielles pour atteindre pleinement la cible de 1% de l’apport énergétique ainsi que les objectifs afférents en matière de santé publique et de protection des populations vulnérables

CMS physics technical design report : Addendum on high density QCD with heavy ions

Peer reviewe

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Background Previous evidence indicates that adjuvant, short-course androgen deprivation therapy (ADT) improves metastasis-free survival when given with primary radiotherapy for intermediate-risk and high-risk localised prostate cancer. However, the value of ADT with postoperative radiotherapy after radical prostatectomy is unclear. Methods RADICALS-HD was an international randomised controlled trial to test the efficacy of ADT used in combination with postoperative radiotherapy for prostate cancer. Key eligibility criteria were indication for radiotherapy after radical prostatectomy for prostate cancer, prostate-specific antigen less than 5 ng/mL, absence of metastatic disease, and written consent. Participants were randomly assigned (1:1) to radiotherapy alone (no ADT) or radiotherapy with 6 months of ADT (short-course ADT), using monthly subcutaneous gonadotropin-releasing hormone analogue injections, daily oral bicalutamide monotherapy 150 mg, or monthly subcutaneous degarelix. Randomisation was done centrally through minimisation with a random element, stratified by Gleason score, positive margins, radiotherapy timing, planned radiotherapy schedule, and planned type of ADT, in a computerised system. The allocated treatment was not masked. The primary outcome measure was metastasis-free survival, defined as distant metastasis arising from prostate cancer or death from any cause. Standard survival analysis methods were used, accounting for randomisation stratification factors. The trial had 80% power with two-sided α of 5% to detect an absolute increase in 10-year metastasis-free survival from 80% to 86% (hazard ratio [HR] 0·67). Analyses followed the intention-to-treat principle. The trial is registered with the ISRCTN registry, ISRCTN40814031, and ClinicalTrials.gov, NCT00541047. Findings Between Nov 22, 2007, and June 29, 2015, 1480 patients (median age 66 years [IQR 61–69]) were randomly assigned to receive no ADT (n=737) or short-course ADT (n=743) in addition to postoperative radiotherapy at 121 centres in Canada, Denmark, Ireland, and the UK. With a median follow-up of 9·0 years (IQR 7·1–10·1), metastasis-free survival events were reported for 268 participants (142 in the no ADT group and 126 in the short-course ADT group; HR 0·886 [95% CI 0·688–1·140], p=0·35). 10-year metastasis-free survival was 79·2% (95% CI 75·4–82·5) in the no ADT group and 80·4% (76·6–83·6) in the short-course ADT group. Toxicity of grade 3 or higher was reported for 121 (17%) of 737 participants in the no ADT group and 100 (14%) of 743 in the short-course ADT group (p=0·15), with no treatment-related deaths. Interpretation Metastatic disease is uncommon following postoperative bed radiotherapy after radical prostatectomy. Adding 6 months of ADT to this radiotherapy did not improve metastasis-free survival compared with no ADT. These findings do not support the use of short-course ADT with postoperative radiotherapy in this patient population

Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

Background Previous evidence supports androgen deprivation therapy (ADT) with primary radiotherapy as initial treatment for intermediate-risk and high-risk localised prostate cancer. However, the use and optimal duration of ADT with postoperative radiotherapy after radical prostatectomy remains uncertain. Methods RADICALS-HD was a randomised controlled trial of ADT duration within the RADICALS protocol. Here, we report on the comparison of short-course versus long-course ADT. Key eligibility criteria were indication for radiotherapy after previous radical prostatectomy for prostate cancer, prostate-specific antigen less than 5 ng/mL, absence of metastatic disease, and written consent. Participants were randomly assigned (1:1) to add 6 months of ADT (short-course ADT) or 24 months of ADT (long-course ADT) to radiotherapy, using subcutaneous gonadotrophin-releasing hormone analogue (monthly in the short-course ADT group and 3-monthly in the long-course ADT group), daily oral bicalutamide monotherapy 150 mg, or monthly subcutaneous degarelix. Randomisation was done centrally through minimisation with a random element, stratified by Gleason score, positive margins, radiotherapy timing, planned radiotherapy schedule, and planned type of ADT, in a computerised system. The allocated treatment was not masked. The primary outcome measure was metastasis-free survival, defined as metastasis arising from prostate cancer or death from any cause. The comparison had more than 80% power with two-sided α of 5% to detect an absolute increase in 10-year metastasis-free survival from 75% to 81% (hazard ratio [HR] 0·72). Standard time-to-event analyses were used. Analyses followed intention-to-treat principle. The trial is registered with the ISRCTN registry, ISRCTN40814031, and ClinicalTrials.gov , NCT00541047 . Findings Between Jan 30, 2008, and July 7, 2015, 1523 patients (median age 65 years, IQR 60–69) were randomly assigned to receive short-course ADT (n=761) or long-course ADT (n=762) in addition to postoperative radiotherapy at 138 centres in Canada, Denmark, Ireland, and the UK. With a median follow-up of 8·9 years (7·0–10·0), 313 metastasis-free survival events were reported overall (174 in the short-course ADT group and 139 in the long-course ADT group; HR 0·773 [95% CI 0·612–0·975]; p=0·029). 10-year metastasis-free survival was 71·9% (95% CI 67·6–75·7) in the short-course ADT group and 78·1% (74·2–81·5) in the long-course ADT group. Toxicity of grade 3 or higher was reported for 105 (14%) of 753 participants in the short-course ADT group and 142 (19%) of 757 participants in the long-course ADT group (p=0·025), with no treatment-related deaths. Interpretation Compared with adding 6 months of ADT, adding 24 months of ADT improved metastasis-free survival in people receiving postoperative radiotherapy. For individuals who can accept the additional duration of adverse effects, long-course ADT should be offered with postoperative radiotherapy. Funding Cancer Research UK, UK Research and Innovation (formerly Medical Research Council), and Canadian Cancer Society

Les débuts du hockey montréalais, 1875-1917

Le hockey a récemment reçu ses lettres de noblesse de la part du gouvernement canadien, à savoir le "sport national d'hiver", tandis que la crosse en est le pendant estival. Sous le leadership du néo-démocrate Nelson Riess, ce projet de loi privé vient confirmer ce que tous et chacun savaient depuis longtemps. La loi C-212 a été déposée le 27 avril 1994, et a reçu la sanction royale le 12 mai suivant. Cependant, peu de gens connaissent réellement son histoire, principalement en ce qui concern..

Partage d’informations et respect de la confidentialité : repères pour améliorer la qualité des services en santé mentale

Objectifs La collaboration entre les personnes proches aidantes (PPA) et les professionnels joue un rôle déterminant dans le rétablissement de la personne vivant avec un trouble mental. Cependant, les pratiques collaboratives entre les PPA et les professionnels se heurtent à des enjeux de confidentialité, particulièrement lorsqu’il est question de partager des informations de manière bidirectionnelle entre les acteurs impliqués. Ce faisant, ces enjeux nuisent à la qualité des services offerts en santé mentale.Méthode Une étude qualitative a permis de rencontrer 19 PPA et 19 professionnels en santé mentale de 2 régions du Québec afin d’identifier les enjeux liés au partage d’informations et au respect de la confidentialité à partir de leur perspective croisée. Des entretiens individuels semi-dirigés ont été réalisés auprès des 38 participants.Résultats La confidentialité et le refus de la personne vivant avec un trouble mental à consentir au partage d’informations demeurent des obstacles importants et actuels dans les pratiques en santé mentale. L’organisation des services en santé mentale devrait assurer une meilleure intégration des PPA dans les équipes afin qu’elles puissent contribuer au rétablissement de la personne et ainsi, recevoir tout le soutien et les informations dont elles ont besoin pour exercer leur rôle. Il ressort de l’étude que les PPA ont différents besoins d’information pour exercer leur rôle et accompagner la personne vivant avec un trouble mental, dont celui d’avoir des renseignements généraux et non confidentiels pour mieux soutenir cette dernière. Tout en respectant les droits fondamentaux et l’autonomie de la personne qui est libre de consentir ou non au partage d’informations la concernant, les professionnels et les PPA peuvent tout de même avoir des échanges et créer une alliance qui favorise l’établissement de collaborations et le rétablissement.Conclusion Cet article offre des repères afin de faciliter le dialogue entre les personnes vivant avec un trouble mental, les PPA et les professionnels et de les soutenir dans leurs actions en matière de partage d’informations et de respect de la confidentialité dans les pratiques en santé mentale. Ultimement, l’intention est de favoriser des pratiques collaboratives qui contribueront à améliorer la qualité des services en santé mentale.Objectives Collaboration between family caregivers and professionals plays a critical role in the recovery of the person living with a mental health disorder. However, collaborative practices between family caregivers and professionals are impeded by issues relating to confidentiality, particularly in connection with bidirectional information sharing between the parties involved. In doing so, these issues affect the quality of mental health services.Method A qualitative study was conducted with 19 family caregivers and 19 mental health professionals from 2 Quebec regions in order to identify issues related to information sharing and confidentiality from their combined perspective. The Photovoice method was used and individuals semi-directed interviews were conducted with the 38 participants.Results Confidentiality and the refusal of the person living with a mental health disorder to consent to share information remains important and current obstacles in mental health practises. The organization of mental health services should ensure better integration of family caregivers into care teams so that they can contribute to the person’s recovery and thus receive all the support and information they need to exercise their role. This study shows that family caregivers have different information needs in order to carry out their role and accompany the person living with a mental health disorder, including the need for general and non-confidential information to better support the person. While respecting the fundamental rights and autonomy of the person, who is free to consent or not to sharing information concerning him or her, professionals and family caregivers can still interact and create an alliance that promotes collaboration and recovery.Conclusion This article offers benchmarks to facilitate dialogue among people living with a mental health disorder, family caregivers and professionals, and to support their actions around information-sharing and respect for confidentiality in mental health practises. Ultimately, the intention here is to foster collaborative practices that will help improve the quality of mental health services